Applications Are Now Being Accepted for a William Bensen MoC Grant
The deadline to apply for a William Bensen MOC Initiative Grant is September 1, 2023. This year, we will be awarding 1 grant to a successful applicant who will receive up to a maximum of […]
Award Recipients Announced!
Congratulations to the following members on well-deserved award recognition: Distinguished Members Award: Dr. Wes Fidler Dr. Jody Lewtas Dr. Alfred Cividino Dr. Vincent Mak (Posthumous Award) Early Career Rheumatologist Dr. Sahil Koppikar […]
CPSO Removes Barriers for Internationally Educated Physicians
The full article is available here: https://www.cpso.on.ca/News/News-Articles/CPSO-Removes-Barriers-for-Internationally-Educated […]
Holiday Message From Dr. Felix Leung
Dear Members of the Ontario Rheumatology Association, As the holiday season approaches, I wanted to take a moment to wish you all a happy and safe holiday season. I hope that you are […]
Biosimilar Transition Policy Announcement in Ontario
On December 20, 2022 the Ontario Ministry of Health announced that effective March 31, 2023, a transition policy will be implemented to expand the use of biosimilar medicines within the public drug program. […]
ORADE Grants Are Back!
The mandate of the Ontario Rheumatology Association Development and Education Committee (ORADE) is to support ORA members and AHP colleagues in their professional development by offering educational grants. Following a 2-year pause due […]
New Biosimilar Fact Sheet Now Available!
The ORA Government Affairs Committee have created a useful tool that organizes biosimilars and their various features, including formulations and LU Codes. You may find the new resource here: Biosimilars […]
Sad News About the Passing of Dr. Vincent Mak
A message from ORA President, Dr. Felix Leung: It is with great difficulty that I must inform you of the sudden passing of our friend and colleague, Dr. Vincent Mak, on Wednesday, August […]
Diversity, Equity and Inclusion Within the ORA
The ORA leadership team recently developed a Diversity, Equity and Inclusion statement that was approved by the Board of Directors. We invite you to scroll down to the bottom of our homepage to […]
Updated ORA Position Statement: Biosimilar Switching
The ORA has recently updated its position statement on biosimilar switching. It is available here: Updated ORA Position Statement Biosimilar Switching […]
